Higher tax outgo pulls Aurobindo's Q4 net profit down 12%

Impacted by higher tax outgo, pharma major Aurobindo Pharma’s posted a 12% drop in consolidated net profit for the fourth quarter ended March 31, 2023, at Rs 506 crore as compared to Rs 576 crore in the corresponding quarter of financial year 2021-22.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/0tRndSz

Comments

Post a Comment

Popular posts from this blog

Global giants bank on Indian-origin CFOs

Image
Indian-origin finance chiefs are increasingly leading global giants like Unilever, Tesla, and Mastercard. A study reveals over a dozen multinational corporations have appointed Indian descent CFOs, many educated in India. This trend highlights the evolving role of CFOs as strategists, adept at navigating complex markets and demonstrating resilience, a skill honed by the Indian education system and professional experiences. from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/r9zfLbi
Read more